Determination of Traditional Chinese Medicine Syndrome of Rat Model of Follicular Dysplasia Induced by Tripterygium Glycosides Based on Prescriptions via AMPK/mTOR/HIF-1/VEGF Pathway
|更新时间:2024-06-14
|
Determination of Traditional Chinese Medicine Syndrome of Rat Model of Follicular Dysplasia Induced by Tripterygium Glycosides Based on Prescriptions via AMPK/mTOR/HIF-1/VEGF Pathway
“The latest research has found that Guishen Wan effectively improves ovarian function and promotes follicle maturation in a rat model of follicular dysplasia by inhibiting the AMPK/mTOR/HIF-1/VEGF signaling pathway. Its therapeutic effect is superior to that of Zuo Gui Yin, You Gui Yin, and Si Wu Tang, providing a new approach for the treatment of kidney essence deficiency syndrome.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 30, Issue 14, Pages: 46-54(2024)
HU Yingying,LIN Xuejuan,ZHUO Zushun,et al.Determination of Traditional Chinese Medicine Syndrome of Rat Model of Follicular Dysplasia Induced by Tripterygium Glycosides Based on Prescriptions via AMPK/mTOR/HIF-1/VEGF Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(14):46-54.
HU Yingying,LIN Xuejuan,ZHUO Zushun,et al.Determination of Traditional Chinese Medicine Syndrome of Rat Model of Follicular Dysplasia Induced by Tripterygium Glycosides Based on Prescriptions via AMPK/mTOR/HIF-1/VEGF Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(14):46-54. DOI: 10.13422/j.cnki.syfjx.20240705.
Determination of Traditional Chinese Medicine Syndrome of Rat Model of Follicular Dysplasia Induced by Tripterygium Glycosides Based on Prescriptions via AMPK/mTOR/HIF-1/VEGF Pathway